Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Biochimica Et Biophysica Acta
|
May 22, 2003
"Blue heart": characterization of a mifepristone-dependent system for conditional gene expression in genetically modified animals
Philip Babij, George Psaltis, Di Song, et al.
The Journal of Biological Chemistry
|
May 16, 2015
Heavy Metal Ion Regulation of Gene Expression: MECHANISMS BY WHICH LEAD INHIBITS OSTEOBLASTIC BONE-FORMING ACTIVITY THROUGH MODULATION OF THE Wnt/β-CATENIN SIGNALING PATHWAY
Eric E Beier, Tzong-Jen Sheu, Deborah Dang, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
October 22, 2002
Smooth muscle-specific expression of SV40 large TAg induces SMC proliferation causing adaptive arterial remodeling
Jürgen R Sindermann, Philip Babij, Joseph C Klink, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
August 14, 2012
Effects of sclerostin antibody on healing of a non-critical size femoral bone defect
Muhammad U Jawad, Kate E Fritton, Ting Ma, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 31, 2009
Small molecules with potent osteogenic-inducing activity in osteoblast cells
Chun-Ya E Han, Youping Wang, Longchuan Yu, et al.
Bone
|
September 30, 2014
Anti-DKK1 antibody promotes bone fracture healing through activation of β-catenin signaling
Hongting Jin, Baoli Wang, Jia Li, et al.
Bone
|
September 6, 2011
Sclerostin expression is induced by BMPs in human Saos-2 osteosarcoma cells but not via direct effects on the sclerostin gene promoter or ECR5 element
Longchuan Yu, Marissa van der Valk, Jin Cao, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 2, 2014
HDAC5 controls MEF2C-driven sclerostin expression in osteocytes
Marc N Wein, Jordan Spatz, Shigeki Nishimori, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 4, 2009
Identification of small molecule inhibitors of proline-rich tyrosine kinase 2 (Pyk2) with osteogenic activity in osteoblast cells
John G Allen, Matthew R Lee, Chun-Ya E Han, et al.
Arthritis and Rheumatism
|
December 13, 2012
Sclerostin is expressed in articular cartilage but loss or inhibition does not affect cartilage remodeling during aging or following mechanical injury
Martine Roudier, Xiaodong Li, Qing-Tian Niu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Biochimica Et Biophysica Acta
|
May 22, 2003
"Blue heart": characterization of a mifepristone-dependent system for conditional gene expression in genetically modified animals
Philip Babij, George Psaltis, Di Song, et al.
The Journal of Biological Chemistry
|
May 16, 2015
Heavy Metal Ion Regulation of Gene Expression: MECHANISMS BY WHICH LEAD INHIBITS OSTEOBLASTIC BONE-FORMING ACTIVITY THROUGH MODULATION OF THE Wnt/β-CATENIN SIGNALING PATHWAY
Eric E Beier, Tzong-Jen Sheu, Deborah Dang, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
October 22, 2002
Smooth muscle-specific expression of SV40 large TAg induces SMC proliferation causing adaptive arterial remodeling
Jürgen R Sindermann, Philip Babij, Joseph C Klink, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
August 14, 2012
Effects of sclerostin antibody on healing of a non-critical size femoral bone defect
Muhammad U Jawad, Kate E Fritton, Ting Ma, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 31, 2009
Small molecules with potent osteogenic-inducing activity in osteoblast cells
Chun-Ya E Han, Youping Wang, Longchuan Yu, et al.
Bone
|
September 30, 2014
Anti-DKK1 antibody promotes bone fracture healing through activation of β-catenin signaling
Hongting Jin, Baoli Wang, Jia Li, et al.
Bone
|
September 6, 2011
Sclerostin expression is induced by BMPs in human Saos-2 osteosarcoma cells but not via direct effects on the sclerostin gene promoter or ECR5 element
Longchuan Yu, Marissa van der Valk, Jin Cao, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 2, 2014
HDAC5 controls MEF2C-driven sclerostin expression in osteocytes
Marc N Wein, Jordan Spatz, Shigeki Nishimori, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 4, 2009
Identification of small molecule inhibitors of proline-rich tyrosine kinase 2 (Pyk2) with osteogenic activity in osteoblast cells
John G Allen, Matthew R Lee, Chun-Ya E Han, et al.
Arthritis and Rheumatism
|
December 13, 2012
Sclerostin is expressed in articular cartilage but loss or inhibition does not affect cartilage remodeling during aging or following mechanical injury
Martine Roudier, Xiaodong Li, Qing-Tian Niu, et al.
Page
of 2